Body
Medically-supervised weight loss
A clinically-supervised programme using prescription-only GLP-1 medications — for people for whom diet and exercise alone have not been enough.
What it is
GLP-1 receptor agonists (Mounjaro, Wegovy, Saxenda) are prescription-only medications originally developed for type 2 diabetes that have shown significant weight-loss benefits in clinical trials. They reduce appetite, slow gastric emptying and improve the body's response to insulin.
Our programme is a structured clinical service. You meet a UK-registered prescriber, complete a thorough medical consultation, have your BMI, blood pressure and history reviewed, and — if eligible — receive your prescription, supplied by our partnered GPhC-registered pharmacies. Monthly reviews follow to monitor progress, manage side effects and adjust dose where appropriate.
What it treats
- Adults with a BMI ≥ 30
- Adults with a BMI ≥ 27 who also have a weight-related health condition (type 2 diabetes, high blood pressure, dyslipidemia, sleep apnoea)
- Plateaus where established diet and lifestyle changes have not produced sustained loss
How it works
- 1 Initial consultation — face-to-face or online — with a UK-registered prescriber. We review your medical history, current medications, weight history, lifestyle, and goals.
- 2 BMI, blood pressure and (where indicated) blood work are reviewed.
- 3 If eligible, a prescription is issued and the medication is dispensed by our partnered GPhC-registered pharmacy.
- 4 Monthly review appointments: progress, side effects, dose titration, and onward planning.
- 5 Lifestyle support — we are explicit that medication alone is not the answer. Diet, movement and sleep all matter.
What to expect
Appointment time
Initial consultation: 30–45 minutes. Monthly reviews: 15–20 minutes.
Downtime
None medically. The first few weeks on any GLP-1 commonly bring nausea, reduced appetite, and changes in bowel habits as your body adjusts.
How it feels
The injection itself is a small subcutaneous needle once a week (Mounjaro, Wegovy) or once a day (Saxenda). Most clients learn to do it themselves at home.
Aftercare
Eat smaller, more nutrient-dense meals. Hydrate well. Avoid very fatty or very heavy foods, particularly in the days after each injection. Tell us about any persistent side effects so we can adjust.
Results visible
Initial reduction in appetite within 1–2 weeks; meaningful weight loss from month 2
How long they last
For most clients, an ongoing monthly programme. Eligible clients may step down gradually under supervision.
Is this right for you?
A good fit if
- You meet the BMI criteria for prescription
- You have tried diet and lifestyle changes that haven't produced sustained results
- You're prepared to combine medication with diet and movement changes
- You can commit to monthly reviews
Not the right time if
- You're pregnant, breastfeeding or planning to become pregnant
- You have a personal or family history of medullary thyroid cancer or MEN2
- You have a history of pancreatitis or significant gallbladder disease
- You're under 18
- Your BMI is below the relevant threshold (we will tell you honestly)
Price
Mounjaro from £180 per month (lowest dose) · Wegovy from £190 · Saxenda from £210. Price increases with dose.
Final price confirmed in your complimentary consultation. Cancellation policy.
Treatments under Medically-supervised weight loss
Mounjaro (tirzepatide)
Once-weekly GLP-1 / GIP injection — currently the strongest weight-loss data.
Learn more
Wegovy (semaglutide)
Once-weekly GLP-1 injection — well-established and widely used.
Learn more
Saxenda (liraglutide)
Once-daily GLP-1 injection — the longest-established option in this class.
Learn moreFAQs
Is this a quick fix?
No. GLP-1 medications change how your body responds to food and hunger, which is powerful — but the foundation is still diet and lifestyle. Clients who treat the medication as a complete solution and don't change anything else are the ones who regain weight when they stop.
Which medication is right for me?
We discuss this in your consultation based on your medical history, weight goals, response history (if any), and budget. Mounjaro currently has the strongest weight-loss data; Wegovy is well-established; Saxenda is daily and may suit some clients better. The right answer depends on you.
What about side effects?
Nausea, reduced appetite, constipation or loose stools, fatigue, and occasionally heartburn are common in the first few weeks. Most settle as the body adjusts. We titrate the dose carefully and adjust if side effects are not manageable.
What happens when I stop?
Appetite typically returns to baseline within weeks. Without lifestyle changes alongside the medication, weight regain is common. We focus our reviews on the lifestyle side specifically so you have something durable to lean on.
How long can I stay on it?
There is no fixed cap. Many clients stay on a maintenance dose for a year or more. We review every month and step the dose down where appropriate.
Who prescribes it?
UK-registered independent prescribers who are part of our clinical team. The medications are dispensed by GPhC-registered pharmacies we partner with.
Related treatments
Mounjaro (tirzepatide)
Once-weekly GLP-1 / GIP injection — currently the strongest weight-loss data.
Learn more Wegovy (semaglutide)
Once-weekly GLP-1 injection — well-established and widely used.
Learn more Saxenda (liraglutide)
Once-daily GLP-1 injection — the longest-established option in this class.
Learn moreReady when you are
Start with a complimentary consultation.
Thirty minutes, in person, at Knightsbridge or Harley Street. We'll listen, look, and tell you honestly what we'd recommend — and what we wouldn't.